Total Funding
87
66
Total FundingGrant raised
Growth Score
-7 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
32424
CrannMed is developing resorbable embolic particles and a custom delivery catheter for the treatment of Knee Osteoarthritis.
- Liam Farrissey: Founder & Chief Executive Officer
- Richard Leyden: Chief Financial Officer
About the Company
CrannMed aims to eliminate chronic pain, restore mobility, and stop disease progression for patients with knee osteoarthritis. Their solution provides an alternative treatment for this debilitating disease through the development of bioresorbable embolic particles and a balloon occlusion microcatheter.
